 |
|
 |
|
| Activities: |
|
| Currently the Academy
is running major clinical studies. The Standard
Operating Procedures ensures data generation
that can submit to international peer review
and GCP /ICH /FDA requirements. In addition
we intend to pursue pure research. Initial
projects on heart autopsies as well as biomedical
material using cell lines are being planned. |
|
| Clinical
trials |
|
| Presently
clinical trial are being carried on
the following indication |
|
 |
Non
Valvular AF |
|
STEMI |
|
GPIIa/IIIb
inhibitors in ACS |
|
Platelet ADP
Blocker in ACS |
|
Poly cap |
|
Oral reversible
ADP receptor antagonist in ACS |
|
|
| Successfully
coordinated and completed 16 trials
in the following indication |
|
|
STEMI |
|
NSTEMI |
|
Unstable angina |
|
Heart Failure |
|
GPIIb/IIIa
Inhibitors in PCI |
|
Peripheral
Arterial Occlusion |
|
Diabetes |
|
Dyslipidemia |
|
Hypercholesteremia |
|
|
- Non invasive
- Left ventricular diastolic relaxation
abnormality in Diabetes mellitus |
| |
- Epedimiology
studies - 02 Studies |
|
|
| Prospective
Clinical trial in the following indications |
|
|
VTE
Prevention |
|
Novel intravenous
platelet receptor antagonist during
PCI |
|
Tissue Doppler
imaging in DM Patients on Rosiglitazone |
|
Platelet ADP
Blocker in ACS |
|
Oral anticoagulant
/ oral antiplatelets in Patients with
Low EF |
|
|
| Registry
/Data collation |
|
| Ongoing
Data collation |
|
|
ACS |
|
Stents: Followup
of patients on Bare/ DES stents since
2000 |
|
|
| Completed
Registry Data collation |
|
|
WHO
premise Refgistry |
|
Dobutamine
stress echo data collection - Total
Patients recruited 550 |
|
Statin Study
- Total Patients recruited 297 |
|
Create Registry
- Total Patients recruited 846 |
|
Homocysteine
CVD Marker Study - Total Patients recruited
116 |
|
Framingham
Heart Study - Total Patients recruited
147 |
|
Taxus |
|
Innocom |
|
Olympia |
|
RIVIERA |
|
CLIMATE |
|
Enoxosure |
|
RENGROWTH |
|
|
| Epidemiology |
|
|
|
|
|
|
|
